• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项测试引导式自主干预效果的随机对照试验中,克服招募障碍显示,精神分裂症患者参与意愿高且辍学率低。

Overcoming recruitment barriers revealed high readiness to participate and low dropout rate among people with schizophrenia in a randomized controlled trial testing the effect of a Guided Self-Determination intervention.

作者信息

Jørgensen Rikke, Munk-Jørgensen Povl, Lysaker Paul H, Buck Kelly D, Hansson Lars, Zoffmann Vibeke

机构信息

Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aalborg University Hospital, Mølleparkvej 10, 9000 Aalborg, Denmark.

出版信息

BMC Psychiatry. 2014 Feb 3;14:28. doi: 10.1186/1471-244X-14-28.

DOI:10.1186/1471-244X-14-28
PMID:24490977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3927263/
Abstract

BACKGROUND

Recruitment is one of the most serious challenges in performing randomized controlled trials. Often clinical trials with participants diagnosed with schizophrenia are terminated prematurely because of recruitment challenges resulting in a considerable waste of resources in the form of time, funding, and the participants' efforts. Dropout rates in schizophrenia trials are also high.Recruitment challenges are often due to patients not wanting to participate in research but can also be due to clinicians' concerns regarding individuals diagnosed with schizophrenia as participants in research. This paper reports how overcoming recruitment challenges not related to patients revealed high readiness to take part and low dropout rates in a one year long randomized controlled trial testing Guided Self-Determination (GSD) among outpatients with schizophrenia receiving treatment in Assertive Outreach Teams in the northern part of Denmark.

METHODS

GSD is a shared decision-making and mutual problem-solving method using reflection sheets, which was developed in diabetes care and adjusted for this study and utilized by patients with schizophrenia. Descriptive data on strategies to overcome recruitment challenges were derived from notes and observations made during the randomized controlled trial testing of GSD in six outpatient teams.

RESULTS

Three types of recruitment challenges not related to patients were identified and met during the trial: 1) organizational challenges, 2) challenges with finding eligible participants and 3) challenges with having professionals invite patients to participate. These challenges were overcome through: 1) extension of time, 2) expansion of the clinical recruitment area and 3) encouragement of professionals to invite patients to the study. Through overcoming these challenges, we identified a remarkably high patient-readiness to take part (101 of 120 asked accepted) and a low dropout rate (8%).

CONCLUSION

Distinction between recruitment challenges was important in discovering the readiness among patients with schizophrenia to take part in and complete a trial with the GSD-intervention.

摘要

背景

招募是进行随机对照试验时最严峻的挑战之一。通常,针对被诊断为精神分裂症患者的临床试验会因招募困难而提前终止,这导致时间、资金以及参与者的努力等资源的大量浪费。精神分裂症试验中的脱落率也很高。招募困难往往是因为患者不想参与研究,但也可能是由于临床医生对被诊断为精神分裂症的个体参与研究存在顾虑。本文报告了在丹麦北部积极外展团队中接受治疗的精神分裂症门诊患者中,一项为期一年的测试引导式自我决定(GSD)的随机对照试验如何克服与患者无关的招募挑战,从而发现患者参与意愿高且脱落率低的情况。

方法

GSD是一种使用反思表的共同决策和共同解决问题的方法,该方法最初在糖尿病护理中开发,本研究对其进行了调整并供精神分裂症患者使用。关于克服招募挑战策略的描述性数据来自在六个门诊团队对GSD进行随机对照试验测试期间所做的记录和观察。

结果

在试验期间识别并应对了三种与患者无关的招募挑战:1)组织方面的挑战,2)寻找符合条件参与者的挑战,3)让专业人员邀请患者参与的挑战。通过以下方式克服了这些挑战:1)延长时间,2)扩大临床招募区域,3)鼓励专业人员邀请患者参与研究。通过克服这些挑战,我们发现患者参与意愿非常高(120名被邀请者中有101名接受邀请)且脱落率低(8%)。

结论

区分招募挑战对于发现精神分裂症患者参与并完成GSD干预试验的意愿很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbf/3927263/66ca6929a843/1471-244X-14-28-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbf/3927263/5d9c0611c87f/1471-244X-14-28-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbf/3927263/66ca6929a843/1471-244X-14-28-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbf/3927263/5d9c0611c87f/1471-244X-14-28-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbf/3927263/66ca6929a843/1471-244X-14-28-3.jpg

相似文献

1
Overcoming recruitment barriers revealed high readiness to participate and low dropout rate among people with schizophrenia in a randomized controlled trial testing the effect of a Guided Self-Determination intervention.在一项测试引导式自主干预效果的随机对照试验中,克服招募障碍显示,精神分裂症患者参与意愿高且辍学率低。
BMC Psychiatry. 2014 Feb 3;14:28. doi: 10.1186/1471-244X-14-28.
2
Factors Associated With Dropout During Recruitment and Follow-Up Periods of a mHealth-Based Randomized Controlled Trial for Mobile.Net to Encourage Treatment Adherence for People With Serious Mental Health Problems.一项基于移动健康的随机对照试验(Mobile.Net)中,与招募期和随访期脱落相关的因素,该试验旨在鼓励严重精神健康问题患者坚持治疗。
J Med Internet Res. 2017 Feb 21;19(2):e46. doi: 10.2196/jmir.6417.
3
The Momentum trial: the efficacy of using a smartphone application to promote patient activation and support shared decision making in people with a diagnosis of schizophrenia in outpatient treatment settings: a randomized controlled single-blind trial.动力试验:使用智能手机应用程序促进门诊治疗环境中诊断为精神分裂症患者的患者激活和支持共享决策的效果:一项随机对照单盲试验。
BMC Psychiatry. 2019 Jun 17;19(1):185. doi: 10.1186/s12888-019-2143-2.
4
Changes in persistent delusions in schizophrenia using guided self-determination: a single case study.精神分裂症中持续性妄想的变化:一项单病例研究。
Issues Ment Health Nurs. 2012 May;33(5):293-300. doi: 10.3109/01612840.2011.653624.
5
Effects on cognitive and clinical insight with the use of Guided Self-Determination in outpatients with schizophrenia: A randomized open trial.在精神分裂症门诊患者中使用引导式自主决定对认知和临床洞察力的影响:一项随机开放试验。
Eur Psychiatry. 2015 Jul;30(5):655-63. doi: 10.1016/j.eurpsy.2014.12.007. Epub 2015 Jan 16.
6
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.早期精神分裂症患者将接受长效抗精神病药物(长效注射剂)的治疗:PRELAPSE 试验招募阶段的结果。
J Clin Psychiatry. 2019 Apr 23;80(3):18m12546. doi: 10.4088/JCP.18m12546.
7
Implementing shared decision-making on acute psychiatric wards: a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS).在急性精神病病房实施共享决策:一项伴有精神分裂症患者的(SDM-PLUS)集群随机试验。
Epidemiol Psychiatr Sci. 2020 Jun 16;29:e137. doi: 10.1017/S2045796020000505.
8
DEVELOPING LIFE SKILLS IN HAEMODIALYSIS USING THE GUIDED SELF-DETERMINATION METHOD: A QUALITATIVE STUDY.运用引导式自我决定法培养血液透析患者的生活技能:一项定性研究。
J Ren Care. 2016 Jun;42(2):83-92. doi: 10.1111/jorc.12146. Epub 2015 Dec 27.
9
Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study).基层医疗中抑郁症的债务咨询:一项适应性随机对照试验(DeCoDer研究)。
Health Technol Assess. 2017 Jun;21(35):1-164. doi: 10.3310/hta21350.
10
Lessons learnt during a complex, multicentre cluster randomised controlled trial: the ProAct65+ trial.在一项复杂的多中心集群随机对照试验中获得的经验教训:ProAct65+ 试验。
Trials. 2013 Jul 1;14:192. doi: 10.1186/1745-6215-14-192.

引用本文的文献

1
Research assistants' experiences recruiting patients with psychosis into clinical trials: a qualitative study.研究助理招募精神病患者参与临床试验的经历:一项定性研究。
Trials. 2025 May 30;26(1):180. doi: 10.1186/s13063-025-08882-y.
2
Positive outcomes for individuals participating in psychosis research.参与精神病研究的个体的积极结果。
Aust N Z J Psychiatry. 2025 Jun;59(6):482-484. doi: 10.1177/00048674251333573. Epub 2025 Apr 16.
3
Effectiveness of a Videoconference-Based Cognitive Behavioral Therapy Program for Patients with Schizophrenia: Pilot Randomized Controlled Trial.

本文引用的文献

1
Exploring patients' reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care.探索初级保健认知行为治疗随机对照试验中患者拒绝联系的原因。
Br J Gen Pract. 2012 May;62(598):e371-7. doi: 10.3399/bjgp12X641492.
2
Changes in persistent delusions in schizophrenia using guided self-determination: a single case study.精神分裂症中持续性妄想的变化:一项单病例研究。
Issues Ment Health Nurs. 2012 May;33(5):293-300. doi: 10.3109/01612840.2011.653624.
3
Realizing empowerment in difficult diabetes care: a guided self-determination intervention.
基于视频会议的认知行为疗法对精神分裂症患者的有效性:试点随机对照试验。
JMIR Form Res. 2025 Jan 14;9:e59540. doi: 10.2196/59540.
4
Prediabetes and cardiovascular risk factors: the effectiveness of a guided self-determination counselling approach in primary health care, a randomized controlled trial.糖尿病前期和心血管危险因素:初级卫生保健中引导自主决策咨询方法的有效性,一项随机对照试验。
BMC Public Health. 2024 Nov 1;24(1):3035. doi: 10.1186/s12889-024-20538-1.
5
Patients' experiences with participating in a team-based person-centred intervention for patients at risk of or diagnosed with COPD in general practice.患者参与基层医疗中针对慢性阻塞性肺疾病风险患者或已确诊患者的团队式以人为本干预措施的体验。
Pilot Feasibility Stud. 2023 Sep 25;9(1):164. doi: 10.1186/s40814-023-01398-9.
6
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study.抗精神病药减量试验的招募:可接受性研究的影响。
BMC Med Res Methodol. 2023 Mar 29;23(1):78. doi: 10.1186/s12874-023-01881-0.
7
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
8
Using Digital Tools to Engage Patients With Psychosis and Their Families in Research: Survey Recruitment and Completion in an Early Psychosis Intervention Program.使用数字工具让精神病患者及其家属参与研究:早期精神病干预项目中的调查招募与完成情况
JMIR Ment Health. 2021 May 31;8(5):e24567. doi: 10.2196/24567.
9
Passive sensing on mobile devices to improve mental health services with adolescent and young mothers in low-resource settings: the role of families in feasibility and acceptability.移动设备上的被动感知,以改善资源匮乏环境中青少年和年轻母亲的心理健康服务:家庭在可行性和可接受性方面的作用。
BMC Med Inform Decis Mak. 2021 Apr 7;21(1):117. doi: 10.1186/s12911-021-01473-2.
10
Perspectives of Trial Staff on the Barriers to Recruitment in a Digital Intervention for Psychosis and How to Work Around Them: Qualitative Study Within a Trial.试验人员对精神病数字干预招募障碍及应对方法的看法:一项试验中的定性研究
JMIR Hum Factors. 2021 Mar 5;8(1):e24055. doi: 10.2196/24055.
实现困难糖尿病护理中的赋权:一项有指导的自主决定干预。
Qual Health Res. 2012 Jan;22(1):103-18. doi: 10.1177/1049732311420735. Epub 2011 Aug 29.
4
Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics.精神分裂症试验参与:感知到的纳入障碍和对抗精神病药物的看法。
Pharmacopsychiatry. 2011 Jun;44(4):123-8. doi: 10.1055/s-0031-1277147. Epub 2011 Jun 27.
5
Barriers to participation in mental health research: findings from the Genetics and Psychosis (GAP) Study.参与心理健康研究的障碍:遗传学与精神病学(GAP)研究的结果。
Int Rev Psychiatry. 2011;23(1):31-40. doi: 10.3109/09540261.2010.546777.
6
Barriers to participation in mental health research: are there specific gender, ethnicity and age related barriers?参与心理健康研究的障碍:是否存在特定的性别、种族和年龄相关障碍?
BMC Psychiatry. 2010 Dec 2;10:103. doi: 10.1186/1471-244X-10-103.
7
The great divide: a qualitative investigation of factors influencing researcher access to potential randomised controlled trial participants in mental health settings.巨大的鸿沟:一项定性研究,调查影响研究人员接触心理健康环境中潜在随机对照试验参与者的因素。
J Ment Health. 2010 Dec;19(6):532-41. doi: 10.3109/09638237.2010.520367.
8
Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder.精神分裂谱系障碍患者心理社会治疗脱落率的荟萃分析。
Schizophr Res. 2010 Aug;121(1-3):266-70. doi: 10.1016/j.schres.2010.04.003. Epub 2010 May 8.
9
A review of reporting of participant recruitment and retention in RCTs in six major journals.对六大期刊中随机对照试验参与者招募和保留情况报告的综述。
Trials. 2009 Jul 10;10:52. doi: 10.1186/1745-6215-10-52.
10
An assessment of the understanding and motivations of patients with schizophrenia about participating in a clinical trial.评估精神分裂症患者对参与临床试验的理解和动机。
Contemp Clin Trials. 2009 Sep;30(5):446-50. doi: 10.1016/j.cct.2009.04.006. Epub 2009 Apr 23.